NG
ABBV icon

Norden Group’s AbbVie ABBV Stock Holding History

Norden Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5M Buy
19,879
+1,232
+7% +$265K 0.41% 50
2026
Q1 		$4.06M Sell
18,647
-750
-4% -$166K 0.39% 54
2025
Q4 		$4.43M Buy
19,397
+501
+3% +$114K 0.43% 47
2025
Q3 		$4.38M Sell
18,896
-237
-1% -$48.3K 0.44% 43
2025
Q2 		$3.55M Sell
19,133
-2,908
-13% -$540K 0.39% 60
2025
Q1 		$4.62M Buy
22,041
+4,360
+25% +$848K 0.53% 38
2024
Q4 		$3.14M Sell
17,681
-70
-0.4% -$12.9K 0.36% 64
2024
Q3 		$3.51M Buy
17,751
+9,091
+105% +$1.7M 0.41% 59
2024
Q2 		$1.49M Buy
8,660
+511
+6% +$84.6K 0.3% 75
2024
Q1 		$1.48M Buy
8,149
+1,672
+26% +$288K 0.3% 76
2023
Q4 		$1M Sell
6,477
-1,968
-23% -$287K 0.17% 73
2023
Q3 		$1.26M Buy
+8,445
New +$1.24M 0.41% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norden Group's ABBV Position: Q2 2026 in Review

Norden Group increased its AbbVie (ABBV) stake by 6.6% in Q2 2026, buying an estimated $265K and bringing the position to 19,879 shares worth $5M. The position accounts for 0.41% of the portfolio, ranked #50.

Norden Group first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Norden Group held 19,879 shares of AbbVie worth $5M as of Q2 2026.
  • Norden Group bought 1,232 AbbVie shares in Q2 2026, an estimated $265K.
  • AbbVie made up 0.41% of Norden Group's portfolio in Q2 2026, its #50 holding.
  • Norden Group first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.